DE69411342D1 - Polypeptid bombesin antagonisten - Google Patents

Polypeptid bombesin antagonisten

Info

Publication number
DE69411342D1
DE69411342D1 DE69411342T DE69411342T DE69411342D1 DE 69411342 D1 DE69411342 D1 DE 69411342D1 DE 69411342 T DE69411342 T DE 69411342T DE 69411342 T DE69411342 T DE 69411342T DE 69411342 D1 DE69411342 D1 DE 69411342D1
Authority
DE
Germany
Prior art keywords
phenyl
alkyl
hydrogen
moiety
10alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69411342T
Other languages
English (en)
Other versions
DE69411342T2 (de
Inventor
Andrew Victor Schally
Ren Zhi Cai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
Original Assignee
Tulane University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tulane University filed Critical Tulane University
Application granted granted Critical
Publication of DE69411342D1 publication Critical patent/DE69411342D1/de
Publication of DE69411342T2 publication Critical patent/DE69411342T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE69411342T 1993-03-15 1994-03-07 Polypeptid bombesin antagonisten Expired - Fee Related DE69411342T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/031,325 US5369094A (en) 1990-11-29 1993-03-15 Polypeptide bombesin antagonists
PCT/US1994/002511 WO1994021674A1 (en) 1993-03-15 1994-03-07 Polypeptide bombesin antagonists

Publications (2)

Publication Number Publication Date
DE69411342D1 true DE69411342D1 (de) 1998-08-06
DE69411342T2 DE69411342T2 (de) 1998-11-19

Family

ID=21858823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69411342T Expired - Fee Related DE69411342T2 (de) 1993-03-15 1994-03-07 Polypeptid bombesin antagonisten

Country Status (27)

Country Link
US (1) US5369094A (de)
EP (1) EP0646127B1 (de)
JP (1) JP3838656B2 (de)
KR (1) KR100306506B1 (de)
AT (1) ATE167874T1 (de)
AU (1) AU666270B2 (de)
BR (1) BR9404341A (de)
CA (1) CA2135787C (de)
CZ (1) CZ286750B6 (de)
DE (1) DE69411342T2 (de)
DK (1) DK0646127T3 (de)
EE (1) EE03180B1 (de)
ES (1) ES2120615T3 (de)
FI (1) FI945378A (de)
HR (1) HRP940164B1 (de)
HU (1) HU218288B (de)
IL (2) IL108851A (de)
NO (1) NO313418B1 (de)
NZ (2) NZ299913A (de)
PL (1) PL180372B1 (de)
RU (1) RU2114118C1 (de)
SI (1) SI9420001B (de)
SK (1) SK282267B6 (de)
TW (1) TW325478B (de)
UA (1) UA34456C2 (de)
WO (1) WO1994021674A1 (de)
ZA (1) ZA941767B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
JP2002506424A (ja) 1997-04-22 2002-02-26 キュレイター オブ ザ ユニバーシィティ オブ ミズーリ ガストリン受容体−親和性ペプチド結合体
IL155814A0 (en) * 2000-11-17 2003-12-23 Warner Lambert Co Treatment of sexual dysfunction using bombesin antagonist
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
ATE435035T1 (de) * 2003-01-13 2009-07-15 Bracco Imaging Spa Verbesserte linker für radiopharmazeutische verbindungen
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
CN1777439A (zh) 2003-04-22 2006-05-24 研究及应用科学协会股份有限公司 生长抑素的载体
US7795385B2 (en) * 2004-12-17 2010-09-14 Bexar Global, Inc. Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
EP2100900A1 (de) * 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin-analoge Peptid-antagonistische Konjugate
EP2198878A1 (de) * 2008-12-18 2010-06-23 University Of Miami Polypeptide Bombesinantagonisten
AU2010303822A1 (en) 2009-10-07 2012-03-15 Merck Sharp & Dohme Corp. Novel TRPA1 antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
GR1000608B (el) * 1988-07-21 1992-08-31 Erba Carlo Spa Μεθοδος για την παρασκευη ανταγωνιστων bombesin.
WO1990003980A1 (en) * 1988-10-14 1990-04-19 Administrators Of The Tulane Educational Fund Therapeutic peptides
US5217955A (en) * 1989-09-15 1993-06-08 Biomeasure, Inc. Treatment of cancer with peptide analog of bombesin, grp, litorin or neuromedin
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists

Also Published As

Publication number Publication date
PL306209A1 (en) 1995-03-06
RU94046091A (ru) 1996-09-27
NO944293D0 (no) 1994-11-10
HUT69727A (en) 1995-09-28
JPH07507330A (ja) 1995-08-10
CZ280794A3 (en) 1995-07-12
JP3838656B2 (ja) 2006-10-25
EP0646127B1 (de) 1998-07-01
TW325478B (en) 1998-01-21
HRP940164A2 (en) 1996-08-31
CA2135787A1 (en) 1994-09-29
KR950701646A (ko) 1995-04-28
EE03180B1 (et) 1999-04-15
IL108851A (en) 2003-05-29
NO313418B1 (no) 2002-09-30
BR9404341A (pt) 1999-08-31
ES2120615T3 (es) 1998-11-01
ATE167874T1 (de) 1998-07-15
SK136494A3 (en) 1995-08-09
DE69411342T2 (de) 1998-11-19
US5369094A (en) 1994-11-29
NO944293L (no) 1995-01-02
UA34456C2 (uk) 2001-03-15
SI9420001A (en) 1995-08-31
IL154995A0 (en) 2003-10-31
AU6444694A (en) 1994-10-11
CA2135787C (en) 2008-08-12
HU218288B (en) 2000-07-28
PL180372B1 (pl) 2001-01-31
AU666270B2 (en) 1996-02-01
EP0646127A1 (de) 1995-04-05
SK282267B6 (sk) 2001-12-03
FI945378A0 (fi) 1994-11-15
SI9420001B (sl) 1999-08-31
IL108851A0 (en) 1994-06-24
NZ299913A (en) 2000-07-28
FI945378A (fi) 1994-11-15
DK0646127T3 (da) 1999-04-12
WO1994021674A1 (en) 1994-09-29
ZA941767B (en) 1994-10-06
CZ286750B6 (en) 2000-06-14
KR100306506B1 (ko) 2001-12-01
RU2114118C1 (ru) 1998-06-27
HRP940164B1 (en) 2000-02-29
NZ263668A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
ATE167874T1 (de) Polypeptid bombesin antagonisten
CA2097192A1 (en) Bombesin antagonists
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
GB1533077A (en) 4-substituted enkephalin derivatives
ES460618A1 (es) Procedimiento para la preparacion de derivados de peptido
GB1526367A (en) Polypeptide
DE3751398T2 (de) Substrat-Peptide.
DE68923572D1 (de) Peptide.
ES416516A1 (es) Un procedimiento para la preparacion de nonapeptidos.
GB1357121A (en) Peptide enzyme inhibitors
GB1363801A (en) Peptides and their preparation
GB1273873A (en) Corticotropically highly active octadecapeptides
TH17064B (th) ตัวปฏิปักษ์ต่อโปลีเปปไทด์บอมเบซิน
ES418929A1 (es) Procedimiento para la preparacion de polipeptidos.
ES248724A1 (es) Procedimiento para la obtenciën de nuevosdecapeptures ciclicos
GB1269898A (en) Amino acid derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee